{"title":"Olutasidenib as a Breakthrough for R/R mIDH1 AML Patients","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009932.86369.ce","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"114 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Times","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.cot.0001009932.86369.ce","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}